Primary care perspectives on prescribing anti‐obesity medication for adolescents
Authors' conclusion
Willingness to prescribe AOM was low and was associated with perceived practicality and appropriateness for patients.
Study context
- Population
- Primary care pediatric physicians and advanced practice providers in an academic-affiliated network20% response rate · Primary care pediatric physicians 187 · advanced practice providers 190
- Participants
- 74 physicians
- Outcome
- Willingness to prescribe AOM for adolescents
Methodological detailssurvey, investigator-developed survey, academic-affiliated network, vignettes, multinomial logistic regression
- Survey
- Investigator-developed survey
- Academic-affiliated network
- Vignettes
- Multinomial logistic regression
Main finding
As reported in the abstract
Willingness to prescribe AOM
Willing to prescribe
24%
Uncertain
42%
Unwilling to prescribe
34%
Observational data: associations, not effects.
Further findings
Agreement that anti-obesity medication (AOM) should be managed only by specialists
- Agreed AOM should be managed only by specialists
- 64%
Factors associated with willingness or unwillingness
- Willingness associated with clinician motivation and belief in guideline practicality and applicability
- Unwillingness associated with beliefs that patients would not continue AOM long enough for benefit and insufficient time or resources to implement
Willingness to prescribe AOM in vignettes
- Patient with severe obesity and metabolic complications
- 52%
- Patient with obesity and possible disordered eating
- 11%
Original publication
Primary care perspectives on prescribing anti‐obesity medication for adolescents. Pediatr Obes. Published 16 June 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →